COMMON WARRANTS OF ALGERNON PHARMACEUTICALS INC. UNDERWRITING AGREEMENTAlgernon Pharmaceuticals Inc. • June 3rd, 2022 • Pharmaceutical preparations • New York
The undersigned, Algernon Pharmaceuticals Inc., a company existing under the laws of the Province of British Columbia, Canada (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of Algernon Pharmaceuticals Inc., the "Company"), hereby confirms its agreement (this "Agreement") with the several underwriters (such underwriters, including the Representative (as defined below), the "Underwriters" and each an "Underwriter") named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the "Representative" and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
COMMON SHARES PURCHASE WARRANT ALGERNON PHARMACEUTICALS INC.Common Shares Purchase • June 3rd, 2022 • Algernon Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS COMMON SHARES PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on ________1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Algernon Pharmaceuticals Inc., a company existing under the laws of the Province of British Columbia, Canada (the "Company"), up to ______ Common Shares (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder
